ZHONGXING LIAO to Clinical Trials as Topic
This is a "connection" page, showing publications ZHONGXING LIAO has written about Clinical Trials as Topic.
Connection Strength
0.307
-
Radiotherapy clinical trial enrollment during the COVID-19 pandemic. Acta Oncol. 2021 Mar; 60(3):312-315.
Score: 0.089
-
Thoracic Radiation Oncology Clinical Trial Accrual and Reasons for Nonenrollment: Results of a Large, Prospective, Multiyear Analysis. Int J Radiat Oncol Biol Phys. 2020 08 01; 107(5):897-908.
Score: 0.085
-
Enhancing clinical trial enrollment at MD Anderson Cancer Center satellite community campuses. Acta Oncol. 2019 Aug; 58(8):1135-1137.
Score: 0.079
-
COX-2 and its inhibition as a molecular target in the prevention and treatment of lung cancer. Expert Rev Anticancer Ther. 2004 Aug; 4(4):543-60.
Score: 0.028
-
Combination of a COX-2 inhibitor with radiotherapy or radiochemotherapy in the treatment of thoracic cancer. Am J Clin Oncol. 2003 Aug; 26(4):S85-91.
Score: 0.027